This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
CHELMSFORD, Mass., May 17, 2013 (GLOBE NEWSWIRE) -- Brooks Automation, Inc. (Nasdaq:BRKS) announced that it had been selected by the Tohoku Medical Mega Bank at Tohoku University to provide multiple Automated Sample Management Systems. As part of a competitive bid process, Tohoku Medical Mega Bank selected Brooks BioStore™ II systems to store up to 4 million samples of DNA, serum and blood plasma as part of multiple, broad population studies including generational studies investigating the impacts of the 2011 tsunami and associated aftereffects. These systems are scheduled to be delivered and installed by March 2014.
The BioStore II systems being supplied to the Tohoku Medical Mega Bank is a biological storage solution that provides high density storage along with redundant -80C cooling systems to ensure scientists that their work is performed on samples of known quality and origin.
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation, vacuum and instrumentation solutions for multiple markets including life sciences, front end semiconductor manufacturing and adjacent technology markets. Our technologies, engineering competencies and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, we have been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; we have expanded our reach to meet the needs of customers in the life sciences industry, analytical & research markets and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia. For more information, please visit
Forward Looking Statements
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause Brooks' financial and business results to differ materially from our expectations. They are based on the facts known to management at the time they are made. These forward-looking statements include statements regarding our ability to manufacture and deliver on schedule automated sample management systems to our customers. Factors that could cause results to differ from our expectations include a possible delay or inability to finalize written contracts governing the terms of sale and the other factors and risks that we have described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly reports on Form 10-Q. As a result we can provide no assurance that our future results will not be materially different from those projected. Brooks expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. Brooks undertakes no obligation to update the information contained in this press release.
CONTACT: Lynne Yassemedis
Senior Managing Director